Featured Research

from universities, journals, and other organizations

HIV treatment use increases in the U.S.

Date:
September 3, 2012
Source:
Johns Hopkins University Bloomberg School of Public Health
Summary:
Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death.

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The study was nested in the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design), which is the largest cohort of HIV-infected adults in North America.

Related Articles


The findings are published in the Sept. 4 edition of Annals of Internal Medicine.

The study included more than 45,000 HIV-infected participants receiving clinical care for HIV. The study population was demographically similar to the U.S. population living with HIV, according to national surveillance data from the Centers for Disease Control and Prevention. Over the study period, the researchers found that the proportion of HIV-infected participants prescribed HAART increased 9 percentage points to 83 percent. During this time, the researchers also observed an increase in viral load suppression among those with HIV, regardless of treatment. Suppression of viral load reduces the likelihood of transmitting HIV to others. Among those taking HAART, the proportion with a suppressed viral load increased from 54 percent to 81 percent.

"This is good news for the HIV epidemic in the U.S., but there is room for improvement," said Keri N. Althoff, PhD, MPH, lead author of the study and assistant professor in the Bloomberg School's Department of Epidemiology. "We need to continue to focus on linking HIV-infected adults into care and effective treatment, not only for the individual's health, but to reduce the likelihood of transmission to others."

The analysis also found an increase in median CD4 count for participants who died from HIV during the study period. Median counts increased at the time of death from 60 cells/mm3 to 209 cells/mm3. A higher CD4 count suggests a healthier immune system. Additional research is planned to investigate trends in the causes of death.

"Our study demonstrates the data from the NA-ACCORD can be used to monitor important health indicators among adults with HIV, which is needed to evaluate the impact of the Affordable Care Act and to measure progress towards the National HIV Strategy goals," said Althoff.

The authors of "U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts among HIV-infected Persons, 2000 to 2008" are Keri N. Althoff, PhD, MPH; Kate Buchacz, PhD, MPH; H. Irene Hall, PhD, MPH; Jinbing Zhang, MS; David B. Hanna, MS; Peter Rebeiro, ScM; Stephen J. Gange, PhD; Richard D. Moore, MD, MHS; Mari Kitahata, MD, MPH; Kelly A. Gebo, MD, MPH; Jeffrey Martin, MD; Amy C. Justice, MD, PhD; Michael Horberg, MD; Robert S. Hogg, PhD; Timothy R. Sterling, MD; Angela Cescon, MPH; Marina B. Klein, MD; Jennifer Thorne, MD, PhD; Heidi Crane, MD, MPH; Michael J. Mugavero, MD; Sonia Napravnik, PhD; Gregory D. Kirk, MD, PhD; Lisa P. Jacobson, ScD; and John T. Brooks, MD, for the North American AIDS Cohort Collaboration on Research and Design.

The researchers were supported by grants from the National Institutes of Health, the Canadian Institutes of Health Research, the Canadian HIV Trials Network, the government of British Columbia, and the U.S. Centers for Disease Control and Prevention.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School of Public Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Keri N. Althoff, Kate Buchacz, H. Irene Hall, Jinbing Zhang, David B. Hanna, Peter Rebeiro, Stephen J. Gange, Richard D. Moore, Mari M. Kitahata, Kelly A. Gebo, Jeffrey Martin, Amy C. Justice, Michael A. Horberg, Robert S. Hogg, Timothy R. Sterling, Angela Cescon, Marina B. Klein, Jennifer E. Thorne, Heidi M. Crane, Michael J. Mugavero, Sonia Napravnik, Gregory D. Kirk, Lisa P. Jacobson, John T. Brooks. U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008. Annals of Internal Medicine, 2012; Sep; 157 (5): 325-335 [link]

Cite This Page:

Johns Hopkins University Bloomberg School of Public Health. "HIV treatment use increases in the U.S.." ScienceDaily. ScienceDaily, 3 September 2012. <www.sciencedaily.com/releases/2012/09/120903221155.htm>.
Johns Hopkins University Bloomberg School of Public Health. (2012, September 3). HIV treatment use increases in the U.S.. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2012/09/120903221155.htm
Johns Hopkins University Bloomberg School of Public Health. "HIV treatment use increases in the U.S.." ScienceDaily. www.sciencedaily.com/releases/2012/09/120903221155.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins